Gregory Pellizzon is a Cardiology physician affiliated with Beaumont Hospital. OpenAlex indexes 9 publications with 728 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1015 S Washington Ave
Saginaw, MI 486012556
Telephone
989-754-3000Provider last certified this registry record 29 May 2026.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Baxter HealthcareProgram year20252 payments
- Novartis Pharmaceuticals CorporationProgram year20255 payments
- Novo Nordisk IncProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
86.9%Adenosine Receptor Agonist20.8%Regadenoson100%Part B, office-administered≥72 patientsBeta blocker15.7%Carvedilol49%Metoprolol Succinate43%Metoprolol Tartrate8%Part D<11 patients+ 13 more classes in this area
Blood & clotting
11.3%Factor Xa inhibitor6.5%Eliquis100%Part D≥35 patientsP2Y12 inhibitor3.5%Clopidogrel100%Part D≥20 patients+ 1 more class in this area
Metabolism & gastrointestinal
1.8%SGLT2 inhibitor1.8%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score)
The American Journal of Cardiology
2004 - Importance of mitral regurgitation inpatients undergoing percutaneous coronaryintervention for acute myocardial infarction
Journal of the American College of Cardiology
2004 - Abbreviated Dosing of N‐Acetylcysteine Prevents Contrast‐Induced Nephropathy After Elective and Urgent Coronary Angiography and Intervention
Journal of Interventional Cardiology
2004 - 1005-46 Percutaneous peripheral intervention is associated with sustained improvement in health-related quality of life
Journal of the American College of Cardiology
2004 - 1061-100 Predictors of reinfarction after ST elevation myocardial infarction and glycoprotein receptor blockade: Analysis from the CADILLAC trial
Journal of the American College of Cardiology
2004
Similar KOLs
Other experts from the same institution or the same specialty.
John P. Burke
Beaumont Hospital
Gilbert Raff
Beaumont Hospital
Robert Safian, MD
Beaumont Hospital
Michael A. Farrell
Beaumont Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”